Chronic Care Center

Beirut 9999

0 studies enrolling now · 6 studies all time

What they study most

Beta-Thalassemia, Chronic Anemia, Erythrocyte Transfusion, Hemoglobin S Disease, Ineffective Erythropoiesis, Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia, Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders, Sickling Disorder Due to Hemoglobin S, Transfusion-dependent Alpha-Thalassemia

Studies at this site

• A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) — Running, not enrolling
• An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia — Completed
• Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia — Completed
• Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload — Stopped early
• Effects of HQK-1001 in Patients With Sickle Cell Disease — Stopped early